George A. Scangos, Director at Vir Biotechnology, Inc. (VIR), sold 55,500 shares at $11.65 ($614K) on 2024-02-26, disclosed to the SEC on 2024-02-26.
Scheduled sale ($614k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.05 | 10,028 | $101K | 16.4% |
| 2 | $10.05 | 10,028 | $101K | 16.4% |
| 3 | $11.65 | 17,722 | $206K | 33.6% |
| 4 | $11.65 | 17,722 | $206K | 33.6% |
| Total | $11.07 avg | 55,500 | $614K | 100% |
| Filing → |
| VIR | SELL | 2024-02-20 | $568K | — | Filing → |
| VIR | SELL | 2023-02-24 | $1.4M | — | Filing → |
| VIR | SELL | 2023-02-21 | $1.5M | — | Filing → |